Stay updated on Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Sign up to get notified when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH banner about the terminology transition from “Artificial Intelligence” to “Super Intelligence” was removed from above the ClinicalTrials.gov page content.
    Difference
    1%
    Check dated 2026-11-07T13:44:19.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-31T14:29:38.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates about a terminology transition, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-24T15:54:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision label advances from v3.7.1 to v3.7.2 while the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T15:46:47.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T15:49:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error instead of the study record, indicating the content is currently inaccessible and the page cannot be viewed as intended.
    Difference
    16%
    Check dated 2026-09-19T19:20:51.000Z thumbnail image

Stay in the know with updates to Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cancer Risk on Dapagliflozin vs Other Antidiabetic: Clinical Trial page.